Analyst Nick Abbott works at WELLS FARGO and is focused on the Healthcare sector with 6 price targets and ratings documented since 2020 spanning on 1 stocks. Analyst's average stock valuation to be materialised ratio is 66.67% with an average time for price targets to be met of 208 days.
Most recent stock forecast was given on MRNA, Moderna, Inc at 13-Aug-2021.
Nick Abbott best performing recommendations are on MRNA (MODERNA, INC).
The best stock recommendation documented was for MRNA (MODERNA, INC) at 8/13/2021. The price target of $145 was fulfilled within 185 days with a profit of $244.78 (62.8%) receiving and performance score of 3.39.
Average potential price target upside
Currently, out of the existing stock ratings of Nick Abbott - 219 which are a Hold (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
180
$33.08 (22.52%)
150
16 days ago
7/8 (87.5%)
$10.77 (10.16%)
103
7.7
Buy
200
$53.08 (36.13%)
165
1 months 1 days ago
5/6 (83.33%)
$9.98 (12.98%)
30
10.06
Hold
93
$-53.92 (-36.70%)
111
1 months 5 days ago
4/20 (20%)
$-65.45 (-40.67%)
30
1.14
Hold
205
$58.08 (39.53%)
209
2 months 5 days ago
27/34 (79.41%)
$29.44 (26.04%)
101
7.25
Hold
208
$61.08 (41.57%)
186
2 months 11 days ago
5/6 (83.33%)
$7.96 (6.91%)
25
5.79
